We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Caspase-2 Drives Progression of Fatty Liver Disease

By LabMedica International staff writers
Posted on 25 Sep 2018
Print article
Image: A photomicrograph of a fibrotic liver section revealed by staining of collagen accumulation in a mouse with human-like NASH (Photo courtesy of the University of California, San Diego).
Image: A photomicrograph of a fibrotic liver section revealed by staining of collagen accumulation in a mouse with human-like NASH (Photo courtesy of the University of California, San Diego).
The enzyme caspase-2 has been shown to be critically linked to the progression of nonalcoholic fatty liver disease (NAFLD) to the more serious and aggressive nonalcoholic steatohepatitis (NASH) form of the syndrome.

NASH is the most aggressive form of non-alcoholic fatty liver disease, which includes a spectrum of chronic liver diseases and has become a leading cause of liver transplants. NAFLD progresses to NASH in response to elevated endoplasmic reticulum (ER) stress. While the onset of simple steatosis requires elevated de novo synthesis of lipids, progression to NASH is triggered by accumulation of hepatocyte-free cholesterol.

Investigators at the University of California San Diego (USA) reported in the September 13, 2018, online edition of the journal Cell that caspase-2, whose expression was found to be ER-stress inducible and elevated in human and mouse NASH, controlled the buildup of hepatic-free cholesterol and triglycerides by activating sterol regulatory element-binding proteins (SREBP).

Caspase-2 co-localized with site 1 protease (S1P) and cleaved it to generate a soluble active fragment that initiated SCAP (SREBP cleavage-activating protein)-independent SREBP1/2 activation in the ER. Elimination of caspase-2 or its pharmacological inhibition prevented diet-induced steatosis and NASH progression in ER-stress-prone mice.

"In NASH-free individuals, the activities of SREBP1 and SREBP2 are kept under control, which is essential for preventing excessive lipid accumulation in the liver," said senior author Dr. Michael Karin, professor of pharmacology at the University of California, San Diego. "However, in NASH patients, something goes awry and the liver continues to turn out excess amounts of triglycerides and cholesterol. This correlates with elevated SREBP1 and SREBP2 activities and increased caspase-2 expression. Our results show that caspase-2 is a critical mediator of NASH pathogenesis, not only in mice but probably in humans as well. While explaining how NASH is initiated, our findings also offer a simple and effective way to treat or prevent this devastating disease."

Related Links:
University of California San Diego

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.